99
Participants
Start Date
November 30, 2011
Primary Completion Date
October 31, 2013
Study Completion Date
October 31, 2013
Niacin
Extended-release niacin will be given with aspirin 325 mg by mouth in the evening and dose-escalated as follows: 500 mg once daily for 4 weeks, 1000 mg once daily for 4 weeks, then 1500 mg once daily for 16 weeks (through week 24)
Aspirin
Aspirin 325 mg will be given by mouth in the evening with extended-release niacin through week 24.
Fenofibrate
Fenofibrate will be administered as 200 mg by mouth once daily for 24 weeks.
NY Univ. HIV/AIDS CRS (401), New York
Moses H. Cone Memorial Hospital CRS (3203), Greensboro
Unc Aids Crs (3201), Chapel Hill
Duke Univ. Med. Ctr. Adult CRS (1601), Durham
Alabama Therapeutics CRS (5801), Birmingham
Case CRS (2501), Cleveland
Univ. of Cincinnati CRS (2401), Cincinnati
Northwestern University CRS (2701), Chicago
University of Colorado Hospital CRS (6101), Aurora
UCLA CARE Center CRS (601), Los Angeles
Harbor-UCLA Med. Ctr. CRS (603), Torrance
University of Washington AIDS CRS (1401), Seattle
University of Southern California (1201), Los Angeles
New Jersey Medical School-Adult Clinical Research Ctr. CRS (31477), Newark
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
NETWORK